Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mersana Therapeutics Inc (NQ: MRSN ) 7.570 +0.130 (+1.75%) Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Mersana Therapeutics Inc < Previous 1 2 3 4 Next > Mersana Therapeutics's Return On Capital Employed Insights May 24, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 03, 2023 Via Benzinga US Stocks Edge Higher; AMD Shares Tank Despite Upbeat Results May 03, 2023 U.S. stocks traded up this morning, ahead of the Federal Reserve’s decision on an interest rate hike. Following the market opening Wednesday, the Dow traded up 0.05% to 33,700.93 while the NASDAQ rose... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 March 16, 2023 Via Benzinga FDA Halts Mersana's Early-Stage Cancer Trial After Patient Death March 13, 2023 Via Benzinga Mersana Therapeutics's Return On Capital Employed Insights November 30, 2022 Via Benzinga With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics January 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 03, 2023 Via Benzinga Mersana Inks Cancer Therapy Development Deal With Merck Germany December 23, 2022 Via Benzinga Recap: Mersana Therapeutics Q3 Earnings November 07, 2022 Mersana Therapeutics (NASDAQ:MRSN) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Mersana Therapeutics... Via Benzinga Myovant Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session October 24, 2022 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary September 12, 2022 Via Benzinga Mersana, GSK Ink $1.36B Biobuck Deal For Cancer-Focused Therapy August 09, 2022 Via Benzinga Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session December 19, 2022 Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Via Benzinga Mersana Shares Climb As FDA Grants Fast Track Status To Triple-Negative Breast Cancer Candidate September 12, 2022 The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ: MRSN) lead candidate XMT-1660 for the treatment of adult patients with advanced or... Via Benzinga Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday November 08, 2022 Gainers Via Benzinga Mersana Therapeutics's Return On Capital Employed Insights September 01, 2022 Mersana Therapeutics (NASDAQ:MRSN) brought in sales totaling $4.28 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 10.5%, resulting in a loss of $52.22... Via Benzinga Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday October 06, 2022 Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 16, 2022 Via Benzinga Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday August 10, 2022 Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session August 09, 2022 Via Benzinga Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session August 09, 2022 Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... Via Benzinga Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2 August 09, 2022 U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday. Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session August 09, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session August 08, 2022 Via Benzinga Earnings Scheduled For August 8, 2022 August 08, 2022 Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter. Via Benzinga Earnings Preview For Mersana Therapeutics August 05, 2022 Mersana Therapeutics (NASDAQ:MRSN) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Mersana... Via Benzinga 89 Biggest Movers From Friday June 21, 2022 Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. Via Benzinga Mersana Therapeutics's Return On Capital Employed Overview June 03, 2022 According to Benzinga Pro data, during Q1, Mersana Therapeutics (NASDAQ:MRSN) posted sales of $2.04 million. Earnings were up 3.52%, but Mersana Therapeutics still reported an overall loss of $47.26... Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
